It's never made sense to me to submit prostate biopsies A-L in separate containers. I'm not an Interventional Radiologist or a Urologist, but when was the last time you saw a Urologic Surgeon remove 1/12 of a prostate? And even for targeted radiation or prostate brachytherapy (radioactive seeds) I would think localizing the neoplasm in a specific quadrant would be sufficient. I've worked in several labs where multiple prostate bxs would be submitted in one container (after agreement by the Clinician and the Pathologist) to save a non-insured patient money.
In my opinion, this is only the beginning. If the Patient Protection and Affordable Care Act kicks in, I think the 15 member Independent Payment Advisory Board is going to be finding A LOT of procedures like this that the government will refuse to pay for. Even if one could make an argument that a procedure is medically sound, these decisions will be made after a cost/benefit analysis. e.g.: Is it beneficial to submit every appendix when the incidence rate of carcinoid tumor of the appendix is 1 in 100,000? (source: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1356383/) Is it worth it to diagnose *Helicobacter *via (highly remunerative) IHC when they can be visualized on an H&E? Especially since there is an inexpensive, simple and safe breath test available. Brace yourselves Histonet, winter is coming. Sincerely, Jay A. Lundgren, M.S., HTL (ASCP) _______________________________________________ Histonet mailing list Histonet@lists.utsouthwestern.edu http://lists.utsouthwestern.edu/mailman/listinfo/histonet